Medicine and Dentistry
Breast Cancer
100%
BRCA1
63%
Ovarian Cancer
27%
Triple Negative Breast Cancer
27%
Biological Marker
20%
Prostate Cancer
18%
BRCA2
15%
Gene Mutation
15%
Axilla
15%
Metastatic Colorectal Cancer
15%
Breast Cancer Cell Line
15%
Colorectal Carcinoma
13%
Mastectomy
13%
Hypoxia
12%
Survival Rate
12%
Cancer Risk
12%
Neoadjuvant Chemotherapy
11%
Nodal Metastasis
10%
Needle Biopsy
10%
Preoperative Systemic Therapy
10%
Fine-Needle Aspiration
10%
Cancer Syndrome
10%
Gut Microbiota
10%
Familial Cancer
10%
Prevalence
9%
Neoplasm
9%
Penetrance
8%
APC
7%
Body Mass Index
7%
microRNA
7%
Anemia
7%
Familial Breast Cancer
7%
Overall Survival
7%
Epidermal Growth Factor Receptor
7%
Real-Time Polymerase Chain Reaction
6%
Uterine Cancer
6%
Familial Adenomatous Polyposis
6%
Breast Reconstruction
6%
Cell Culture
6%
Cancer Susceptibility
6%
Recurrent Disease
6%
Prognostic Factor
6%
Progression Free Survival
6%
Genetic Screening
6%
Cancer Specific Survival
5%
microRNA 31
5%
Combination Therapy
5%
Breast Tumor
5%
Cell Line
5%
Disease Specific Survival
5%
Dysbiosis
5%
Population Research
5%
Adjuvant Chemotherapy
5%
Trastuzumab
5%
In Vitro
5%
COVID-19
5%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
5%
Second Trimester Pregnancy
5%
Phlebothrombosis
5%
Erythrocyte
5%
Checkpoint Kinase 2
5%
microRNA 214
5%
Hereditary Nonpolyposis Colorectal Cancer
5%
Organoid
5%
Contralateral
5%
Genotype Phenotype Correlation
5%
Hamartoma
5%
Staphylococcus Aureus
5%
Proteome
5%
MCF-7
5%
Urinary System
5%
Clinical Guideline
5%
Lung Adenocarcinoma
5%
CYP24A1
5%
Meticillin
5%
Cross Sectional Study
5%
Methamidophos
5%
Allele
5%
Chromothripsis
5%
Chronic Venous Insufficiency
5%
Twin Pregnancy
5%
Fragile X Syndrome
5%
Multifocal Motor Neuropathy
5%
Aeromonas
5%
Differentiated Thyroid Cancer
5%
Mass Screening
5%
Clear Cell Renal Cell Carcinoma
5%
Pediatrics Patient
5%
Hepatocellular Carcinoma
5%
Gastroenteritis
5%
Mortality Rate
5%
Survival Prediction
5%
Bladder Cancer
5%
Thyroid Cancer
5%
Hypercalcaemia
5%
Hemorrhoid
5%
Bleeding
5%
Geographic Distribution
5%
Antioxidant
5%
Noonan Syndrome
5%
Biochemistry, Genetics and Molecular Biology
BRCA1
64%
Cancer Cell
36%
Real-Time Polymerase Chain Reaction
28%
CHEK2
24%
Germ Cell
21%
Germline
21%
Gene Mutation
19%
BRCA2
18%
Penetrance
15%
MSH2
14%
Genetic Screening
12%
MLH1
12%
MSH6
11%
Cohort Study
11%
Germline Mutation
10%
Progression Free Survival
10%
Chromothripsis
10%
Intron
10%
Prevalence
9%
Overall Survival
8%
Next Generation Sequencing
8%
Telomere Length
8%
Single-Nucleotide Polymorphism
8%
Proband
8%
Genotyping
7%
Estrogen Receptor
7%
Gene Expression Profiling
7%
Dynamics
7%
Genetic Counseling
7%
Quantitative Reverse Transcription Polymerase Chain Reaction
7%
Allele
6%
Genetic Risk
6%
Missense Mutation
6%
MicroRNA
6%
Cancer Specific Survival
6%
Population Research
6%
Enzyme
6%
Exon
6%
Survival Rate
5%
Disease Specific Survival
5%
Dideoxynucleotide Sequencing
5%
Recurrence Free Survival
5%
Carcinogenesis
5%
Telomere
5%
KRAS
5%
Frameshift Mutation
5%
Phlebothrombosis
5%
Medical Genomics
5%
Electric Power Plant
5%
Staphylococcus Aureus
5%
Cancer Genetics
5%
Genotype Phenotype Correlation
5%
Denaturing High Performance Liquid Chromatography
5%
NOD2
5%
Mass Screening
5%
Neovascularization (Pathology)
5%
Proteome
5%
Methicillin Susceptible Staphylococcus Aureus
5%
Protein-Protein Interaction Networks
5%
Blood Plasma
5%
Genome Instability
5%
Mesenchymal-Epithelial Transition
5%
Karyotype
5%
Doxorubicin
5%
Coding Region
5%
Survival Prediction
5%
Brassinosteroid
5%
Cell Culture
5%
Geographic Distribution
5%
Cell Cycle
5%
Polygenic Score
5%
Haplotype
5%
Anabolism
5%
PTPN11
5%
Epidermal Growth Factor Receptor
5%
Chlorophyll
5%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
28%
Biological Marker
14%
Prostate Cancer
12%
Metastatic Colorectal Cancer
10%
Triple Negative Breast Cancer
10%
Colorectal Carcinoma
9%
Hypoxia
7%
Familial Adenomatous Polyposis
7%
Recurrent Disease
7%
APC
6%
Survival Rate
6%
Cancer Specific Survival
6%
Hereditary Tumor Syndrome
6%
Ovary Cancer
5%
Recurrence Risk
5%
Epidermal Growth Factor Receptor
5%
Combination Therapy
5%
Breast Tumor
5%
Pharmacokinetics
5%
Hereditary Nonpolyposis Colorectal Cancer
5%
Hemorrhoid
5%
microRNA 31
5%
Intestine Flora
5%
Polyposis
5%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
5%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
5%
Differentiated Thyroid Cancer
5%
Survival Prediction
5%
Lung Adenocarcinoma
5%
Erlotinib
5%
Thyroid Cancer
5%
Olaparib
5%
Pharmacodynamics
5%
Renal Cell Carcinoma
5%
microRNA
5%
Carboxylate
5%
Phase IV
5%
Rotavirus
5%
Cross-Sectional Study
5%